On Tuesday, Opko Health Inc. (NYSE:OPK)’s shares inclined 0.71% to $15.63.
Opko Health Inc. (OPK) may fit the first condition of being at or near its highs, but it does not fulfill the second. Those short Opko don’t seem to mind all that much, being that 44.92M shares are presently held short, constituting 67% of the float. That’s about a million more shares than last month, representing over $15M in capital spent on shorting the stock in one month, at least.
While shorting itself may tend to discourage some retail investors from taking a position, institutional investors in addition to company insiders are usually astute enough to know that for every short seller, there is a buyer of those shares on the other side. Close to 70% of Opko’s float is held by either insiders or institutions, and it is doubtful that any of those shares will be put on the open market any time soon. And even if some are, the company’s founder and CEO, Dr. Phillip Frost, is picking shares at the same pace that shortsellers are borrowing them to sell.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics. The company develops various solutions to diagnose, treat, and prevent various conditions, counting point-of-care tests, molecular diagnostics tests, laboratory developed tests, and proprietary pharmaceuticals and vaccines. Its products comprise 4Kscore test that measures the blood plasma levels of four different prostate-derived kallikrein proteins.
Invesco Ltd. (NYSE:IVZ)’s shares gained 0.57% to $39.15.
Invesco Ltd. (IVZ) declared portfolio administration changes for the following Invesco closed-end municipal funds (the “Funds”):
The following individuals are jointly and primarily responsible for the day-to-day administration of each Fund’s portfolio:
William Black, Portfolio Manager, who has been associated with Invesco and/or its associates since 2010. From 1998 to 2010, Mr. Black was associated with Van Kampen Asset Administration and/or its associates in an investment administration capacity.
Thomas Byron, Portfolio Manager, who has been associated with Invesco and/or its associates since 2010. From 1981 to 2010, Mr. Byron was associated with Van Kampen Asset Administration and/or its associates in an investment administration capacity.
Mark Paris, Portfolio Manager, who has been associated with Invesco and/or its associates since 2010. From 2002 to 2010, Mr. Paris was associated with Van Kampen Asset Administration and/or its associates in an investment administration capacity.
James Phillips, Portfolio Manager, who has been associated with Invesco and/or its associates since 2010. From 1991 to 2010, Mr. Phillips was associated with Van Kampen Asset Administration and/or its associates in an investment administration capacity.
Robert Stryker, Portfolio Manager, who has been associated with Invesco and/or its associates since 2010. From 1994 to 2010, Mr. Stryker was associated with Van Kampen Asset Administration and/or its associates in an investment administration capacity.
Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client focused equity, balanced and fixed income portfolios.
At the end of Tuesday’s trade, Coty Inc (NYSE:COTY)‘s shares surged 1.15% to $31.80.
Coty Inc (COTY) declared that Bart Becht will remain as Interim Chief Executive Officer of Coty. Mr. Becht will also continue in his role as Chairman of Coty. In connection with this change, Elio Leoni Sceti, who was planned to assume the role of CEO in July, has reconsidered and decided not to join Coty.
Coty Inc., together with its auxiliaries, manufactures, markets, and distributes women’s and mens fragrances, color cosmetics, and skin and body care related products worldwide. The company operates through three segments: Fragrances, Color Cosmetics, and Skin & Body Care. It offers various fragrance products under the Calvin Klein, Davidoff, Marc Jacobs, Chloé, Playboy, Balenciaga, Beyoncé, Bottega Veneta, Guess?, Lady Gaga Fame, Roberto Cavalli, and Katy Perry brands; and color cosmetics products, counting lip, eye, nail, and facial color products under the OPI, Rimmel, and Sally Hansen brands.
Corenergy Infrastructure Trust Inc (NYSE:CORR), ended its Tuesday’s trading session with -9.13% loss, and closed at $6.07.
Corenergy Infrastructure Trust Inc (CORR) declared that it intends to offer, subject to market and other conditions, 11.25 million shares of common stock in an underwritten public offering. CorEnergy also intends to allow the underwriters a 30-day option to purchase up to an additional 1.6875 million shares of the common stock, at the public offering price, less the underwriting discount.
Simultaneously, CorEnergy intends to offer $75 million of unsecured convertible senior notes. CorEnergy also intends to allow the underwriters a 30-day option to purchase up to an additional $11.25 million of unsecured convertible senior notes at the public offering price, less the underwriting discount.
CorEnergy Infrastructure Trust, Inc. is an open-ended equity trust launched and managed by Corridor InfraTrust Administration, LLC. The trust primarily owns midstream and downstream U.S. energy infrastructure assets subject to long-term triple net participating leases with energy companies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
